Letter by Spiering et al Regarding Article, "Effect of Denosumab or Alendronic Acid on the Progression of Aortic Stenosis: A Double-Blind Randomized Controlled Trial"

Circulation. 2021 Nov 30;144(22):e334. doi: 10.1161/CIRCULATIONAHA.121.055622. Epub 2021 Nov 29.

Authors

Wilko Spiering¹, Willem P Mali², Pim A de Jong²

Affiliations

¹ Departments of Vascular Medicine (W.S.), University Medical Center Utrecht, The Netherlands.
² Radiology (W.P.M., P.A.d.J.), University Medical Center Utrecht, The Netherlands.

PMID: 34843397
DOI: 10.1161/CIRCULATIONAHA.121.055622

No abstract available

Publication types

Letter
Comment

MeSH terms

Alendronate
Aortic Valve Stenosis* / diagnostic imaging
Aortic Valve Stenosis* / drug therapy
Denosumab* / adverse effects
Double-Blind Method
Humans

Substances

Denosumab
Alendronate